EMBRYONAL RHABDOMYOSARCOMA
Clinical trials for EMBRYONAL RHABDOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new EMBRYONAL RHABDOMYOSARCOMA trials appear
Sign up with your email to follow new studies for EMBRYONAL RHABDOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise against aggressive childhood cancer
Disease control OngoingThis study tests whether adding a drug called vinorelbine to standard chemotherapy can better control high-risk rhabdomyosarcoma, a cancer that often returns or spreads. About 118 children and young adults will receive either the standard treatment or the new combination, followe…
Matched conditions: EMBRYONAL RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 17, 2026 05:30 UTC
-
Could adding temsirolimus boost chemo for childhood muscle cancer?
Disease control OngoingThis study compares standard chemotherapy (VAC/VI) to the same chemo plus temsirolimus in people up to age 40 with intermediate-risk rhabdomyosarcoma, a muscle cancer. The goal is to see if adding temsirolimus improves event-free survival (time without cancer worsening or returni…
Matched conditions: EMBRYONAL RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
Gene hunt: new study seeks clues to childhood muscle cancer
Knowledge-focused OngoingThis study looks at genetic changes in children with a rare muscle cancer called rhabdomyosarcoma. Researchers will compare DNA from the child and both parents to find new gene mutations linked to the disease. The goal is to better understand what causes the cancer and how it may…
Matched conditions: EMBRYONAL RHABDOMYOSARCOMA
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC